191.50SEK+0.29%Mkt Cap: 51.51B SEKP/E: 21.84Last update: 2026-05-13
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, a…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.84
P/E (Forward)17.29
PEG1.52
P/B1.66
P/S1.51
EV/EBITDA10.72
EV/Revenue1.72
EPS (TTM)8.66
EPS (Forward)10.94
Cash Flow & Leverage
FCF Yield5.68%
FCF Margin8.58%
Operating CF3.95B SEK
CapEx (TTM)1.31B SEK
Net Debt/EBITDA1.28
Net Debt6.97B SEK
Technical
SMA 50190.39 (+0.6%)
SMA 200205.30 (-6.7%)
Beta0.78
S&P 52W Chg24.23%
Avg Vol (30d)691.67K
Avg Vol (10d)669.45K
Technical Indicators
RSI (14)51.3
MACD-1.0494
MACD Signal-1.2421
MACD Hist.+0.1927
BB Upper204.95 SEK
BB Middle192.16 SEK
BB Lower179.38 SEK
BB Width13.30%
ATR (14)4.282 SEK
Vol Ratio (20d)0.34x
52W Range
175.9028% of range231.60
52W High231.60 SEK
52W Low175.90 SEK
Profitability
Gross Margin47.63%
EBITDA Margin16.02%
Profit Margin6.46%
Oper. Margin9.92%
ROE7.67%
ROA4.00%
Revenue Growth-10.50%
Earnings Growth33.70%
Balance Sheet
Debt/Equity0.37
Current Ratio1.35
Quick Ratio0.84
Book Value/Sh113.72 SEK
Cash/Share14.76 SEK
Dividends
Fwd Div Rate4.750 SEK
Trail. Div Rate4.750 SEK
Div. Yield2.51%
5Y Avg Yield1.84%
Payout Ratio53.12%
Ex-Div DateApr 22, 2026
Pay Date—
Splits
Last Split4:1
Split DateNov 27, 2003
Ownership
Shares Out.254.15M
Float178.56M
Insiders15.76%
Institutions65.19%
Analyst Consensus
Rating—
Target (Mean)224.70 SEK
Target Range165.00 SEK – 270.00 SEK
# Analysts10
Company
Market Cap51.51B SEK
Enterprise Value58.54B SEK
Revenue (TTM)34.09B SEK
Gross Profit16.65B SEK
Net Income (TTM)2.26B SEK
Revenue/Share125.17 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.8K
Last Price191.50 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS37427X1046